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Abstract:  Förster  resonance  energy  transfer  (FRET)  is  a  powerful 
biological tool for reading out cell signaling processes. In vivo use of FRET 
is  challenging  because  of  the  scattering  properties  of  bulk  tissue.  By 
combining  diffuse  fluorescence  tomography  with  fluorescence  lifetime 
imaging  (FLIM),  implemented  using  wide-field  time-gated  detection  of 
fluorescence excited by  ultrashort laser pulses in a tomographic imaging 
system and applying inverse scattering algorithms, we can reconstruct the 
three dimensional  spatial localization of  fluorescence quantum  efficiency 
and lifetime. We demonstrate  in vivo spatial  mapping of FRET between 
genetically expressed fluorescent proteins in live mice read out using FLIM. 
Following  transfection  by  electroporation,  mouse  hind  leg  muscles  were 
imaged in vivo and the emission of free donor (eGFP) in the presence of free 
acceptor (mCherry) could be clearly distinguished from the fluorescence of 
the donor when directly linked to the acceptor in a tandem (eGFP-mCherry) 
FRET construct. 
© 2011 Optical Society of America 
OCIS codes: (170.2655) Functional monitoring and imaging; (170.3010) Image reconstruction 
techniques;  (170.3650)  Lifetime-based  sensing;  (170.3660)  Light  propagation  in  tissues; 
(170.3880) Medical and biological imaging; (170.6960) Tomography. 
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1. Introduction 
The combination of genetically encoded fluorescent proteins and Förster resonance energy 
transfer (FRET) has become an important tool for reading out cell signaling processes [1,2] 
and a significant arsenal of FRET probes has been developed. To date, such readouts have 
been  largely  confined  to  fluorescence  microscopy  of  cells  in  culture.  It  is  becoming 
increasingly important to translate FRET assays to small animal imaging where the in vivo 
physiological  context  is  important  for  drug  development,  the  study  of  diseases  and 
fundamental cellular and molecular biology [3]. 
FRET  is  the  radiationless  transfer  of  energy  from  an  excited  donor  fluorophore  to  an 
appropriate  acceptor  in  close  proximity  and  is  accompanied  by  a  reduction  of  the  donor 
fluorescence  lifetime  and  quantum  yield.  Because  fluorescence  lifetime  measurements  are 
inherently  ratiometric  and  therefore  relatively  insensitive  to  variations  in  fluorophore 
concentration, optical scattering and detection efficiency [4], FLIM provides one of the most 
robust quantitative methods for mapping FRET. 
We are developing a tomographic imaging capability for small animals that utilizes FLIM 
to read out and localize FRET, which  we  have demonstrated by applying it  to live  mice 
transfected with genetically expressed fluorophores. The ability to localize and quantitatively 
reconstruct fluorescence parameters in biological tissues is limited by absorption and by the 
diffusive  nature  of  light  transport  in  such  highly  scattering  media.  Diffuse  imaging  and 
tomography  has  been  extensively  investigated  in  brain  and  breast  tissue,  achieving  ~cm 
spatial  precision  using  near  infra-red  radiation  [5]  but  optical  scattering  and  absorption 
preclude imaging with visible radiation with such large samples. However, the smaller length 
scale (sub-cm) associated with murine tomography can permit the use of shorter wavelength 
(visible)  emitting  fluorophores,  including  genetically  expressed  labels  such  as  eGFP,  and 
allows such fluorophores to be mapped with greater spatial precision. When imaging mice, the 
diffuse  nature  of  light  transport  still  presents  a  significant  challenge  for  accurate  optical 
measurements. However, the instrumentation for time-resolved detection that is required to 
determine fluorescence lifetimes also provides a means to characterize diffuse light transport 
and,  by  employing  a  time-resolved  model  for  diffuse  optical  tomography,  we  are  able  to 
reconstruct three dimensional maps of fluorescence lifetime and quantum yield, as well as the 
optical properties of the sample [6]. 
We note that, although FLIM and FRET are well established for cell microscopy, FLIM 
has only recently been demonstrated in live mouse models, implemented with tomography to 
image  dye  phantoms  and  subcutaneous  tumors  targeted  with  a  fluorescent  marker  [7]  or 
expressing a fluorescent protein [8]. To date, intensity-based FRET tomography [9] and FLIM 
FRET have only been applied to mice ex vivo [8]. We report here a tomographic approach to 
monitor in vivo FLIM FRET readouts and demonstrate for the first time the reconstruction of 
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non-invasive approach can facilitate the in vivo localization of appropriate FRET probes for 
biomedical  research  and  drug  discovery,  permitting  longitudinal  studies  with  a  reduced 
number of animals. 
2. Materials and methods 
2.1. Experimental setup and acquisition conditions 
Using the experimental setup illustrated in Fig. 1, we applied FLIM to read out FRET in live 
mice expressing GCLink, a FRET construct in which eGFP (donor) is directly coupled by a 
short flexible linker to mCherry (acceptor). Plasmids were transfected by electroporation into 
the right hind leg. This procedure primarily targets the tibialis anterior (TA) muscle although 
it does label some of the surrounding  muscles  in  the anterior lateral quadrant of the  leg. 
Control mice were co-transfected with plasmids separately coding for eGFP and mCherry to 
co-express the free donor and acceptor fluorophores. At the peak of GCLink expression (5 or 
6 days after transfection) the mice were anaesthetized and positioned on a rotating imaging 
platform such that their legs could be tomographically imaged in a transmission geometry 
(Fig. 1, panel b). eGFP was excited using ultrashort (~10 ps) pulses of radiation at 480 nm (40 
nm spectral width) from a spectrally filtered ultrafast supercontinuum laser source that was 
focused on the surface of the mouse leg. The laser beam incident at the sample was typically 
of 10 mW average power and illuminated an area of 0.2 mm
2, corresponding to an intensity of 
5 Wcm
2. The exposure time varied from mouse to mouse depending on the expression level 
of the eGFP and the attenuation of its fluorescence. Total image acquisition times per mouse 
varied from 492 s to 2364 s with an average of 1112 s. The transmitted excitation light and the 
emitted fluorescence were imaged onto a time-gated optical intensifier (GOI) and sequentially 
read out using a charge couple device (CCD) camera (Fig. 1, panel a). 
 
Fig. 1. Schematic of the in vivo time-gated imaging setup. (a) Ultrashort pulses of radiation 
from a spectrally filtered supercontinuum laser were focused on the surface of the mouse leg. 
The emerging fluorescence light distribution was imaged onto the GOI and read out using the 
CCD. (b) The anaesthetized mouse was positioned on the imaging platform, which was set on a 
motorised rotation stage controlled by the PC. The target leg was held under slight tension by 
an elastic band. M, Mirror; F1, Filter 1; F2, Filter 2; L, Lens; IR1, Image Relay 1; IR2, Image 
Relay 2; GOI, Gated-Optical Intensifier; CCD, Charged-Couple Device camera; PC, Personal 
Computer. 
Wide-field  time-gated  images  were  acquired  at  each  of  12  angular  orientations.  For 
efficient computation, the time-resolved tomographic fluorescence image stacks were Fourier 
transformed  to  the  frequency  domain  and  the  3-D  fluorescence  lifetime  distribution  was 
reconstructed under the assumption of a mono-exponential fluorescence decay profile using 
an  inverse  scattering  algorithm  based  on  a  variational  framework  [10].  Besides  the 
fluorescence lifetime, this algorithm also reconstructed the 3-D distribution of fluorophore 
quantum  yield  (defined  as  the  ratio  of  the  emitted  fluorescence  energy  to  the  absorbed 
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individual component parts of this procedure follow together with the anatomical/structural 
imaging techniques that were used to verify the localization of the signals obtained. 
2.2. DNA plasmids 
Standard splicing PCR was used to generate the fused expression construct GCLink. In brief, 
full-length open reading frames of enhanced Green Fluorescent Protein (pEGFP-C1 vector, 
Clontech) and mCherry (pmCherry-C1 vector, Clontech) were amplified with an overlapping 
region  consisting  of  a  glycine-glycine-serine-glycine-glycine-serine  linker.  The  two  gel 
purified products were mixed and a second PCR initiated with oligos allowing amplification 
of  a  fused  construct.  The  fused  PCR  product  was  gel  purified  and  cloned  into  pTriEx4 
(Novagen). Cloned constructs were verified by sequencing. 
2.3. In vivo plasmid electroporation 
Plasmid DNA was transformed into JM109 bacteria (Promega) and purified using EndoFree 
plasmid kits (Qiagen). DNA was ethanol precipitated and resuspended in phosphate buffered 
saline, pH 7.4 (Invitrogen) to a concentration of 1 μg/μl (GCLink) or 1.5 μg/μl (individual 
eGFP and mCherry fluorophores). 
In vivo experiments were conducted on 6- to 8-week old CD1 female mice. Animals were 
housed in a minimal disease facility with ad libitum food and water. Animals were placed 
under  general  anaesthetic  by  peritoneal  injection  of  the  following  mixture:  one  part 
fentanyl/fluanisone (Hypnorm, Janssen  Animal Health),  one part  midazolam (Roche), two 
parts distilled water at 10 ml/kg. TA muscles were pretreated by injecting 0.4 U/μl bovine 
hyaluronidase (H-4272, Sigma) in 25 μl normal saline, 1 hr before plasmid injection. Plasmid 
DNA was injected percutaneously in a proximal to distal direction inside the TA muscle. A 
total of 25 μg plasmid DNA was injected into the muscle using a 1 ml insulin syringe with an 
integrated 29G needle. Following the intramuscular injection of plasmid DNA an electric field 
was applied to the muscle as previously described [11]. The injected leg was held steady and 7 
mm circular electrodes (Tweezertrodes, Harvard Apparatus) were applied to the medial and 
lateral sides of the lower hind limb. An electric field of 175 V/cm was applied in 20 ms square 
wave pulses 10 times at 1 second intervals using a BTX ECM 830 electroporator. Optical 
acquisition took place 5 or 6 days after the injection of plasmid DNA, at the height of protein 
expression. 
2.4. In vivo imaging 
All  animal  experiments  were  carried  out  under  license  from  the  Home  Office  (UK)  in 
accordance with The Animal (Scientific Procedure) Act 1986 and Imperial College London 
guidelines. 
General  anesthesia  was  induced  in  mice  as  described  above  and  maintained  by  i.p. 
injection of 0.3 ml/kg fentanyl/fluanisone when necessary. Body temperature was monitored 
and maintained using a jet of warm air. Vital parameters such as heart beat frequency and 
blood oxygenation were monitored using a pulse oximeter (STARR). Hair was chemically 
removed from the electroporated leg using depilatory cream. 
Anaesthetized  mice  were  positioned  in  a  custom-built  platform  on  a  rotation  stage 
(URS75CC, Newport Corp) with the target leg held under tension by an elastic band so that it 
remained approximately aligned with the axis of rotation. The filtered pulsed supercontinuum 
source (SC400-2, Fianium Ltd) was focused to ~0.5mm spot on the surface of the leg. The 
excitation and fluorescence light transmitted through the leg was imaged at 480nm and 530 
nm respectively each with a 40nm bandwidth. Sequential acquisitions were obtained with the 
time-gated optical intensifier (HRI, Kentech Instruments Ltd) read out by the CCD camera 
(ORCA, Hamamatsu Photonics UK Ltd). The intensifier’s gate-width was set to 1 ns and the 
excitation and fluorescence light was sampled over a 10 ns window at 250 ps intervals such 
that the growth and decay of the optical signals were acquired. Synchronization was achieved 
using a photodiode trace from the excitation source as a trigger signal for the HRI via a 
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Ltd).  This  acquisition  procedure  was  repeated  at  12  angular  orientations  collected  (~30° 
separation) with the lateral spot position centered to within 1mm for each orientation. The 
geometrical positions of the excitation spots were measured separately at the end of each 
experiment so that the source position is known for each image set. In addition, silhouette 
images (shadowgrams) were acquired at 1° rotation steps over a complete revolution and used 
to extract the surface of the mouse leg using a filtered back-projection algorithm. 
2.5. MRI acquisition 
Following optical acquisition the mouse was euthanized by terminal anesthetic overdose. To 
maintain  its  pose  the  leg  was  embedded  in  1%  agarose  (Sigma).  When  the  agarose  had 
solidified,  the  leg  was  cut  away  from  the  rest  of  the  body  at  the  level  of  the  hip.  The 
embedded leg was then imaged at 9.4 T (Varian Inc) in a 35 mm birdcage transmit-receiver 
coil (Rapid Biomedical) using a multi-slice T1 weighted spin echo acquisition (TR = 500 ms, 
TE = 8.74 ms) acquired transverse to the leg with a slice thickness of 0.5 mm and 59 μm x 59 
μm in-plane resolution. 
2.6. Confocal fluorescence microscopy and whole leg histology 
Electroporated legs were excised post mortem and the TA muscles removed, mounted on a 
cork block, embedded in O.C.T. compound (BDH Laboratory Supplies) and snap-frozen in 
liquid  nitrogen-cooled  isopentane.  Samples  were  stored  at  80°C.  To  verify  transfection, 
frozen muscles and whole legs were sliced using a cryostat. Transverse sections were cut at a 
thickness of 80 μm and lifted onto poly-L-lysine-coated slides (VWR). Cryosections were 
fixed in 4% formaldehyde with 4% sucrose for 20 minutes at room temperature, washed in 
PBS and mounted in Vectashield (Vectorlabs). Confocal fluorescence images were acquired 
on a Leica TCS SP5 confocal microscope with a HC PL APO 20x/0.70NA objective lens. 
eGFP was excited at 488 nm and detected at 499-540 nm, while mCherry was excited at 561 
nm and detected at 600-684 nm. Transverse leg sections were acquired using an Olympus 
SZX16  fluorescence  microscope  with  an  SDFPLAPO  0.5x  parfocal  objective  lens  and 
appropriate filters to observe eGFP and mCherry. 
2.7. Spectroscopy analysis 
Plasmid  DNA  was  transiently  transfected  into  HEK293T  cells  using  a  standard  PEI 
transfection protocol [12]. Transfected cells were homogenized in ice cold lysis buffer: 50 
mM mannitol, 2 mM EDTA, 50 mM Tris HCl, pH 7.4 with complete protease inhibitors 
(Roche). Nuclei and debris were pelleted by centrifugation at 500 g for 10 min at 4°C, and the 
supernatant was loaded onto a cushion of 300 mM mannitol, 50 mM Tris-HCl, pH 7.6 and 
complete protease inhibitors. The total membrane fraction was pelleted by centrifugation at 
40,000 g for 45 min at 4°C, and the supernatant was collected as a cytosol preparation and 
stored at 80°C. 
Fluorescence lifetime cuvette measurements were performed with an in-house built time-
resolved spectrofluorometer [13] that incorporates a tunable supercontinuum excitation source 
(SPC-400, Fianium Ltd). eGFP was excited at 488 nm using a 10 nm bandpass filter and 
emission was collected at 510 nm via a 10 nm bandpass filter. Time-resolved detection was 
implemented using time-correlated single photon counting (TCSPC) with a photomultiplier 
tube (PMC-100, Becker & Hickl GmbH, Berlin, Germany) connected to TCSPC electronics 
(SPC-730, Becker & Hickl GmbH). To analyze the fluorescence data, the instrument response 
function (IRF) was acquired at the excitation wavelength using a colloidal silica suspension 
(LUDOX® SM-30, Aldrich Chemical Company Inc.) and included in the fitting model. All 
fluorescence lifetime measurements were carried out by exciting the sample with a vertical 
polarization and measuring its emission at the magic angle polarization. 
Lifetime  data  analysis  of  eGFP  was  conducted  by  using  a  double  exponential  decay 
model, see Eq. (1) below, convolved with the IRF. 
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Fitting of the experimental data  was performed  with TRFA Data Processor Advanced 
(SSTC, Minsk, Belarus). The average lifetime ( ) was calculated following Eq. (2): 
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2.8. Tomographic reconstruction 
Tomographic ―image‖ reconstruction was based on the principle of implementing a numerical 
model of diffuse light propagation (the forward model) and fitting this model to the measured 
data (inverse problem). This inverse scattering approach provides the most probable (in the a 
posteriori sense) three dimensional distribution of optical and fluorescence parameters to have 
produced the experimentally  measured data, known as the  Maximum A Posteriori (MAP) 
estimate. In general, this is an ill-posed problem and the resulting reconstructions should be 
considered  as  statistical  indications  of  fluorophore  distributions  rather  than  conventional 
images that have a direct voxel by voxel correspondence to the sample. 
The model of light propagation in the time domain, where the measurements are taken, is 
given by the Telegraph equation approximation to the Radiative Transfer Equation; for more 
details  see  reference  [14].  To  solve  the  equations  more  efficiently,  we  first  convert  the 
measured data into the frequency domain by fast Fourier transform (FFT) and then use the 
Helmholtz equation for the light model (the Fourier equivalent of the Telegraph model) at 
multiple harmonic samples that can be solved in parallel. The model was implemented on a 
Cartesian grid by utilizing the Finite Volume numerical scheme. The computational domain is 
split into computational cells (voxels), whose dimensions correspond to the pixel dimensions 
in  the  CCD  array.  The  computational  mesh  was  built  using  a  filtered  back  projection  of 
shadowgrams  of  the  mouse’s  leg,  acquired  at  1°  angular  steps.  The  total  number  of 
computational voxels varied from 300,000 to 500,000 depending on leg’s size. 
In addition to modeling light propagation inside the leg, a method is required for mapping 
the experimentally recorded time-gated ―images‖ onto the surface of the scattering object. 
This mapping is performed by converting the intensity recorded by the CCD camera to the 
energy density by taking into account an angular dependence of radiation leaving the surface. 
For this purpose we employ the method of Schwarzschild-Shuster [15], which results in an 
image brightness correction factor (½ + cosθ)
-1, where θ is the angle between surface normal 
and direction to the CCD camera. 
Model fitting for the inverse problem is based on  minimization of an error functional 
representing  the  squared  difference  between  the  measured  and  modeled  data  for  both 
excitation  and  fluorescence.  Because  the  inverse  problem  is  strongly  ill-posed,  the  error 
functional is augmented by a regularization functional [10,15]. The minimization is carried 
out by a nonlinear conjugate gradient (NLCG) algorithm constrained by the solution of the 
forward problem. The functional gradient used in the NLCG algorithm is computed using the 
solution of the forward problem and a corresponding adjoint problem for each position of the 
laser source. The solution of the adjoint problem uses the same computational  grid as the 
forward problem applied in reverse to calculate the light distribution solved using the CCD 
array as a source. The resulting system represents the Karush-Kuhn-Tucker conditions [16] 
for optimization of the error norm with the given light transport model. Since an iteration of 
the  forward  problem  requires  the  solution  of  four  Helmholtz  equations  for  excitation, 
fluorescent  and  two  corresponding  adjoint  energy  densities,  computation  of  optical  and 
fluorescence parameters may take up to 7 minutes for each projection angle on a 2.16 GHz 
processor.  In  total,  reconstruction  takes  up  to  2  hours  for  12  projection  angles  at  one 
frequency. 
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Figure  2  shows  cross  sections  from  tomographic  reconstructions  of  the  eGFP  donor 
fluorescence lifetime distributions from imaging the hind legs in two live transfected mice. 
Panel (a) corresponds to a leg containing muscles expressing the FRET construct, GCLink, 
whilst  panel  (b)  displays  the  non-FRETing  control  co-expressing  eGFP  and  mCherry 
separately and panel (c) shows the corresponding lifetime histograms for both. 
 
Fig. 2. Transverse sections from tomographic reconstructions of MRI and fluorescence lifetime 
from in vivo measurements of mouse hind legs. Panels show leg cross sections from (a) mouse 
3 expressing GCLink and (b) mouse 4 co-expressing eGFP and mCherry, with left image: 
MRI; central image: reconstructed MAP lifetime distribution (τ); right image: merged. Panel 
(c) shows fluorescence lifetime histograms of tomographic reconstructions from mice 3 and 4. 
These values are extracted from a volume defined by the top 30% of the calculated quantum 
yield distribution. 
Table 1 summarizes the eGFP reconstructed lifetimes and quantum yields from in vivo 
time-gated measurements of five mice and calculated from a volume defined by the top 30% 
of the reconstructed quantum yield distribution. 
Averaging over the data from all five animals, the mean eGFP lifetime was 1.335 ± 0.234 
ns (n = 3) for mice expressing GCLink and 2.238 ± 0.164 ns for the control mice (n = 2). The 
donor  eGFP  of  the  GCLink  FRET  construct  thus  exhibits  a  consistently  lower  mean 
fluorescence lifetime compared to the free eGFP co-expressed with mCherry, showing that the 
lifetime reduction is specific to the GCLink FRET construct and is not due to intermolecular  
 
#146182 - $15.00 USD Received 18 Apr 2011; revised 6 Jun 2011; accepted 10 Jun 2011; published 10 Jun 2011
(C) 2011 OSA 1 July 2011 / Vol. 2,  No. 7 / BIOMEDICAL OPTICS EXPRESS  1913Table 1. Mean eGFP fluorescence lifetimes and quantum yields 
Mouse # 
Average 
Lifetime (ns)  SD 
Average 
Quantum Yield  SD 
1 GCLink  1.308  0.223  0.058  0.005 
3 GCLink  1.116  0.270  0.068  0.006 
5 GCLink  1.582  0.159  0.068  0.006 
2 eGFP + mCherry  2.354  0.245  0.058  0.005 
4 eGFP + mCherry  2.122  0.341  0.081  0.007 
 
Table 2. Time-resolved fluorescence spectroscopy of cytosol preparations of eGFP, 
GCLink and eGFP + mCherry 
   p1  τ1 (ns)  p2  τ2 (ns)  χ2    (ns) 
eGFP  0.13  1.46  0.87  2.71  1.169  2.61 
GCLink  0.40  0.80  0.60  2.42  1.289  2.13 
eGFP + mCherry  0.11  1.41  0.89  2.69  1.051  2.61 
 
Fig. 3. Time-resolved fluorescence spectroscopy of cytosol preparations of eGFP, GCLink and 
eGFP + mCherry. The experimental data are displayed in blue, the fitting model in red and the 
Instrument Response Function (IRF) is displayed in black. At the bottom of the figure the 
residuals of the fits are shown. 
FRET or to other factors associated with the local fluorophore environment. This reduction of 
eGFP  donor  lifetime  due  to  FRET  correlates  with  cuvette  measurements  of  the  same 
fluorophores in solution; see Table 2 and Fig. 3. 
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presented in Table 1) do not match the values from cuvette measurements (2.61 ns and 2.13 ns 
for the control and FRET constructs respectively). This is mainly due to the limitations of 
tomographic  reconstruction  of  diffuse  fluorescence  signals  (see  Methods)  although  some 
variation  may  also  be  due  to  the  properties  of  the  fluorescent  proteins.  In  particular,  the 
variation in the lifetime of eGFP within the FRET construct may be due to partial maturation 
of the mCherry acceptor [17]. The essential point, however, is that FRET can be detected in 
vivo  via  a  decrease  in  the  absolute  values  of  the  tomographically  reconstructed  donor 
fluorescence lifetime and this can provide a usable readout to localize sites of protein-protein 
interactions  or  FRET  biosensors.  We  note  that  tissue  autofluorescence  could  also  lead  to 
incorrect reconstruction of fluorescence lifetime and quantum yields but we believe that this 
was not a significant issue for this experiment. To confirm this we compared the signals from 
mouse legs with and without the fluorescence proteins expressed. The autofluorescence signal 
was approximately 200x lower than the signal from eGFP in our detection window of 530 ± 
20 nm. 
In principle, FLIM is not required to map FRET since it can be read out via changes in 
quantum efficiency,  which could be approximated by the reconstructed quantum  yield. In 
practice, however, it is often not possible to reconstruct sufficiently quantitative data from 
steady-state  fluorescence  intensity  measurements.  Even  for  reconstructions  from  time-
resolved data, such as we present here, the quantum yield is a less reliable indicator of FRET 
than the fluorescence lifetime because it can be modified by absorption of the fluorescence by 
the sample and by background absorption of the excitation radiation. This is borne out by 
Table 1. Nevertheless, it provides a useful indication of the fluorophore distribution and this 
was used to identify the voxels over which the mean fluorescence lifetimes were calculated. 
Figure 4 shows reconstructed quantum yield distributions for the two samples shown in Fig. 2. 
 
Fig. 4. Tomographic reconstructions of quantum yield distributions from in vivo FLIM of hind 
leg muscles. Leg cross sections expressing GCLink (a) and co-expressing eGFP and mCherry 
(b). Left side panel: MRI; central panel: reconstructed MAP quantum yield distribution (η); 
right panel: merged. 
The  localization  of  the  reconstructed  fluorescence  distributions  in  the  anterior  lateral 
quadrant of the leg was verified by magnetic resonance imaging (MRI) acquired post mortem 
at the end of the in vivo optical experiments. Figures 2 and 4, panels (a) and (b), show the co-
aligned MRI and reconstructed optical data separately and overlaid. In 3/5 cases the peak of 
the reconstructed signal distribution is located within the expected quadrant of the leg and in a 
fourth  case  the  detected  signals  were  just  outside  this  region.  We  note  that  an  apparent 
discrepancy in reconstructed fluorophore localization may reflect the actual distribution of the 
expressed fluorescence protein. To confirm the colocalization of eGFP and mCherry in the 
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fluorescence microscopy. Figure 5, panel (a), shows that the fluorescence signals appear in the 
upper right leg quadrant, where the TA resides. The eGFP and mCherry fluorescence signals 
were observed to be overlaid as expected in both a GCLink transfected mouse (Fig. 5, panel 
b) as well as in a control mouse (panel c), confirming the validity of the control. 
 
Fig.  5.  Co-location  of  transfected  fluorophores.  Panel  (a)  shows  fluorescence  microscope 
images of a whole leg section of a mouse transfected with GCLink with left image eGFP 
signal;  central  image:  mCherry  signal;  right  image:  combined  bright  field  and  fluorescent 
images with overlay of two fluorescent signals in yellow. Panels (b) and (c) show confocal 
sections of TA muscles from mice transfected either with GCLink (b) or eGFP and mCherry 
(c) respectively  with left image: eGFP signal; central image: mCherry signal; right image: 
overlaid. 
4. Conclusions 
To our knowledge this is the first report of in vivo tomographic fluorescence lifetime mapping 
of a FRET probe genetically expressed in a small animal. It provides a key advance towards 
the practical application of FLIM FRET to read out molecular interactions and biosensors in 
vivo.  We  note  that  the  precision  of  fluorophore  localization  can  be  compromised  by  the 
absorption  and  scattering  of  excitation  and  fluorescence  radiation  and  by  the  background 
autofluorescence of the biological tissue. The impact of absorption and scattering could be 
mitigated  by  engineering  FRET  probes  with  donor-acceptor  combinations  utilizing 
fluorophores  that  are  both  excited  and  emit  at  longer  wavelengths,  such  as  red  and  near 
infrared  fluorescent  proteins.  A  recent  study  has  shown  the  advantage  of  red-shifted 
fluorescent  protein  for  in  vivo  tomographic  imaging  and  demonstrated  that,  while 
autofluorescence  is  still  a  significant  issue,  it  can  be  accounted  for  in  the  tomographic 
reconstruction  to  provide  improved  sensitivity,  spatial  localization  and  reduced  image 
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image acquisition process and investigating the trade-off between the number of time gates 
and the number of projection angles. We note that the time-resolved image data could also be 
acquired in the frequency domain using a sinusoidally modulated wide-field detector and we 
expect that both time and frequency domain approaches could be optimized to reach a similar 
level of performance. With appropriately engineered fluorophores, the plethora of existing 
genetically  expressed  intracellular  FRET  biosensors  could  be  exploited,  reading  out 
intracellular messengers such as calcium, IP3, GTP and PIP2, in addition to a vast array of 
intermolecular FRET readouts of protein binding [19,20]. In the current study we imaged the 
hind leg muscle because it provides a convenient target for in vivo plasmid transfection that 
allowed us to efficiently express our fluorescent probes in the same cells that make the organ, 
the myotubes, without alteration of its anatomical architecture. The creation of genetically 
modified  mice  expressing  FRET  probes  would  permit  imaging  in  almost  any  anatomical 
location and would facilitate longitudinal studies in a variety of research fields. Examples of 
such studies include: tracking tumor growth, progression and metastasis, xenograft rejection, 
reperfusion toxicity in brain and heart ischaemic models as well as assessing the effectiveness 
of pharmacological intervention. 
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